Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 25;354(6315):1048-1051.
doi: 10.1126/science.aah6219.

Directed evolution of cytochrome c for carbon-silicon bond formation: Bringing silicon to life

Affiliations

Directed evolution of cytochrome c for carbon-silicon bond formation: Bringing silicon to life

S B Jennifer Kan et al. Science. .

Abstract

Enzymes that catalyze carbon-silicon bond formation are unknown in nature, despite the natural abundance of both elements. Such enzymes would expand the catalytic repertoire of biology, enabling living systems to access chemical space previously only open to synthetic chemistry. We have discovered that heme proteins catalyze the formation of organosilicon compounds under physiological conditions via carbene insertion into silicon-hydrogen bonds. The reaction proceeds both in vitro and in vivo, accommodating a broad range of substrates with high chemo- and enantioselectivity. Using directed evolution, we enhanced the catalytic function of cytochrome c from Rhodothermus marinus to achieve more than 15-fold higher turnover than state-of-the-art synthetic catalysts. This carbon-silicon bond-forming biocatalyst offers an environmentally friendly and highly efficient route to producing enantiopure organosilicon molecules.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Heme protein-catalyzed carbon-silicon bond formation
(A) Carbon–silicon bond formation catalyzed by heme and purified heme proteins. (B) Surface representation of the heme-binding pocket of wild-type Rma cyt c (PDB ID: 3CP5). (C) “Active site” structure of wild-type Rma cyt c showing a covalently bound heme cofactor ligated by axial ligands H49 and M100. Amino acid residues M100, V75 and M103 residing close to the heme iron were subjected to site-saturation mutagenesis. (D) Directed evolution of Rma cyt c for carbon–silicon bond formation (reaction shown in (A)). Experiments were performed using lysates of E. coli expressing Rma cyt c variant (OD600 = 15; heat-treated at 75 °C for 10 min), 10 mM silane, 10 mM diazo ester, 10 mM Na2S2O4, 5 vol% MeCN, M9-N buffer (pH 7.4) at room temperature under anaerobic conditions for 1.5 h. Reactions performed in triplicate. (E) Carbon–silicon bond forming rates over four generations of Rma cyt c.
Fig. 2
Fig. 2. Scope of Rma cyt c V75T M100D M103E-catalyzed carbon–silicon bond formation
Standard reaction conditions: lysate of E. coli expressing Rma cyt c V75T M100D M103E (OD600 = 1.5; heat-treated at 75 °C for 10 min), 20 mM silane, 10 mM diazo ester, 10 mM Na2S2O4, 5 vol% MeCN, M9-N buffer (pH 7.4) at room temperature under anaerobic conditions. Reactions performed in triplicate. [a] OD600 = 5 lysate. [b] OD600 = 0.5 lysate. [c] OD600 = 15 lysate. [d] 10 mM silane. [e] OD600 = 0.15 lysate.
Fig. 3
Fig. 3. Chemoselectivity and in vivo activity of evolved Rma cyt c
(A) Chemoselectivity for carbene Si–H insertion over N–H insertion increased dramatically during directed evolution of Rma cyt c. Standard reaction conditions as described in Fig. 2. Reactions performed in duplicate using heat-treated lysates of E. coli expressing Rma cyt c with protein concentration normalized across variants. Product distribution was quantified after 2 h reaction time (before complete conversion, no double insertion product was observed under these conditions). (B) In vivo synthesis of organosilicon compound 22.

Comment in

  • Teaching nature the unnatural.
    Klare HF, Oestreich M. Klare HF, et al. Science. 2016 Nov 25;354(6315):970. doi: 10.1126/science.aal1951. Science. 2016. PMID: 27884992 No abstract available.

Similar articles

Cited by

References

    1. Frampton MB, Zelisko PM. Organosilicon biotechnology. Silicon. 2009;1:147–163.
    1. Rappoport Z, Apeloig Y, editors. The Chemistry of Organic Silicon Compounds. Vol. 3 Wiley; 2003.
    1. Ponomarenko SA, Kirchmeyer S. Conjugated organosilicon materials for organic electronics and photonics. Adv Polym Sci. 2011;235:33–110.
    1. Showell GA, Mills JS. Chemistry challenges in lead optimization: Silicon isosteres in drug discovery. Drug Discov Today. 2003;8:551–556. - PubMed
    1. Franz AK, Wilson SO. Organosilicon molecules with medicinal applications. J Med Chem. 2013;56:388–405. - PubMed

Publication types